De novo mutations in epileptic encephalopathies Nature 501 (7466), 217-221, 2013 | 1530 | 2013 |
Instruction manual for the ILAE 2017 operational classification of seizure types RS Fisher, JH Cross, C D'souza, JA French, SR Haut, N Higurashi, ... Epilepsia 58 (4), 531-542, 2017 | 1339 | 2017 |
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial EA Thiele, ED Marsh, JA French, M Mazurkiewicz-Beldzinska, ... The Lancet 391 (10125), 1085-1096, 2018 | 869 | 2018 |
De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies S Appenzeller, R Balling, N Barisic, S Baulac, H Caglayan, D Craiu, ... The American Journal of Human Genetics 95 (4), 360-370, 2014 | 461 | 2014 |
Chronic disorders with episodic manifestations: focus on epilepsy and migraine SR Haut, ME Bigal, RB Lipton The Lancet Neurology 5 (2), 148-157, 2006 | 411 | 2006 |
ILAE definition of the idiopathic generalized epilepsy syndromes: position statement by the ILAE task force on nosology and definitions E Hirsch, J French, IE Scheffer, A Bogacz, T Alsaadi, MR Sperling, ... Epilepsia 63 (6), 1475-1499, 2022 | 301 | 2022 |
Seizure occurrence: precipitants and prediction SR Haut, CB Hall, J Masur, RB Lipton Neurology 69 (20), 1905-1910, 2007 | 272 | 2007 |
Rating scales, scales of measurement, issues of reliability: resolving some critical issues for clinicians and researchers D Cicchetti, R Bronen, S Spencer, S Haut, A Berg, P Oliver, P Tyrer The Journal of nervous and mental disease 194 (8), 557-564, 2006 | 272 | 2006 |
Susceptibility of immature and adult brains to seizure effects SR Haut, J Veliškova, SL Moshé The Lancet Neurology 3 (10), 608-617, 2004 | 261 | 2004 |
Health‐related quality of life over time since resective epilepsy surgery SS Spencer, AT Berg, BG Vickrey, MR Sperling, CW Bazil, S Haut, ... Annals of neurology 62 (4), 327-334, 2007 | 188 | 2007 |
Molecular evolution of the telomere-associated MAL loci of Saccharomyces. MJ Charron, E Read, SR Haut, CA Michels Genetics 122 (2), 307-316, 1989 | 183 | 1989 |
Ultra-rare genetic variation in common epilepsies: a case-control sequencing study AS Allen, ST Bellows, SF Berkovic, J Bridgers, R Burgess, G Cavalleri, ... The Lancet Neurology 16 (2), 135-143, 2017 | 176 | 2017 |
Reduction in perceived stress as a migraine trigger: testing the “let-down headache” hypothesis RB Lipton, DC Buse, CB Hall, H Tennen, TA DeFreitas, TM Borkowski, ... Neurology 82 (16), 1395-1401, 2014 | 172 | 2014 |
Trigger factors and premonitory features of migraine attacks: summary of studies JM Pavlovic, DC Buse, CM Sollars, S Haut, RB Lipton Headache: The Journal of Head and Face Pain 54 (10), 1670-1679, 2014 | 165 | 2014 |
Seizure clustering SR Haut Epilepsy & behavior 8 (1), 50-55, 2006 | 154 | 2006 |
EEG findings in acutely ill patients investigated for SARS‐CoV‐2/COVID‐19: a small case series preliminary report AS Galanopoulou, V Ferastraoaru, DJ Correa, K Cherian, S Duberstein, ... Epilepsia open 5 (2), 314-324, 2020 | 152 | 2020 |
Seizure clusters: characteristics and treatment SR Haut Current opinion in neurology 28 (2), 143-150, 2015 | 148 | 2015 |
Seizure clustering during epilepsy monitoring SR Haut, C Swick, K Freeman, S Spencer Epilepsia 43 (7), 711-715, 2002 | 144 | 2002 |
Stress and epilepsy: a patient perception survey SR Haut, M Vouyiouklis, S Shinnar Epilepsy & Behavior 4 (5), 511-514, 2003 | 143 | 2003 |
Seizure clustering: risks and outcomes SR Haut, S Shinnar, SL Moshé Epilepsia 46 (1), 146-149, 2005 | 140 | 2005 |